04 October 2024
04 October 2024
The company’s bone regeneration product is designed to transform spinal fusion surgeries.
The assay identifies mpox infections through DNA analysis of samples taken from pustular or vesicular rashes.
The platform's low-cost sequencing capabilities could significantly benefit Myriad's emerging products.
Elucid’s AI software helps physicians visualise arterial plaque build-up to assess patients’ risk of cardiovascular disease (CVD).
Blood samples from over 500 newborn babies have already been collected across 13 NHS hospitals in England.
The clearance means that patients will soon be able to administer their own influenza vaccine in a bid to take stress away from healthcare services.
REDx QAPs enhance quality management systems in certified clinical labs, ensuring accurate patient diagnostics.
The CE marking clears the way for the company to market its PET system across the EU after launching in the US market in July.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
